PROPECIA Israel - English - Ministry of Health

propecia

organon pharma israel ltd., israel - finasteride - film coated tablets - finasteride 1 mg - finasteride - finasteride - propecia is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss

FINASTERIDE tablet, film coated United States - English - NLM (National Library of Medicine)

finasteride tablet, film coated

mckesson packaging services business unit of mckesson corporation - finasteride (unii: 57gno57u7g) (finasteride - unii:57gno57u7g) - finasteride 5 mg - finasteride is indicated for the treatment of symptomatic benign prostatic hyperplasia (bph) in men with an enlarged prostate to: -improve symptoms -reduce the risk of the need for surgery including transurethral resection of the prostate (turp) and prostatectomy. finasteride is contraindicated in the following: hypersensitivity to any component of this medication. pregnancy. finasteride use is contraindicated in women when they are or may potentially be pregnant. because of the ability of type ii 5α-reductase inhibitors to inhibit the conversion of testosterone to dht, finasteride may cause abnormalities of the external genitalia of a male fetus of a pregnant woman who receives finasteride. if this drug is used during pregnancy, or if pregnancy occurs while taking this drug, the pregnant woman should be apprised of the potential hazard to the male fetus. (see also warnings, exposure of women — risk to male fetus and precautions, information for patients and pregnancy.) in female rats, low doses of finasterid

FINASTERIDE tablet, film coated United States - English - NLM (National Library of Medicine)

finasteride tablet, film coated

physicians total care, inc. - finasteride (unii: 57gno57u7g) (finasteride - unii:57gno57u7g) - finasteride 5 mg - finasteride is indicated for the treatment of symptomatic benign prostatic hyperplasia (bph) in men with an enlarged prostate to: -improve symptoms -reduce the risk of the need for surgery including transurethral resection of the prostate (turp) and prostatectomy. finasteride is contraindicated in the following: hypersensitivity to any component of this medication. pregnancy. finasteride use is contraindicated in women when they are or may potentially be pregnant. because of the ability of type ii 5α-reductase inhibitors to inhibit the conversion of testosterone to dht, finasteride may cause abnormalities of the external genitalia of a male fetus of a pregnant woman who receives finasteride. if this drug is used during pregnancy, or if pregnancy occurs while taking this drug, the pregnant woman should be apprised of the potential hazard to the male fetus. (see also warnings, exposure of women — risk to male fetus and precautions, information for patients and pregnancy .) in female rats, low dos

PRO-CURE 5 MG Israel - English - Ministry of Health

pro-cure 5 mg

merck sharp & dohme israel ltd - finasteride - tablets - finasteride 5 mg - finasteride - finasteride - for the treatment and control of benign prostatic hyperplasia (bph) and for the prevention of urologic events to: reduce the risk of acute urinary retention. reduce the risk of surgery including transurethral resection of the prostate (turp)and prostatectomy. pro-cure causes regression of the enlarged prostate, improves urinary flow and improves the symptoms assocciated with bph. patients with an enlarged prostate are the appropriate candidates for therapy with pro-cure.

FINASTERIDE tablet, film coated United States - English - NLM (National Library of Medicine)

finasteride tablet, film coated

dr reddys laboratories inc - finasteride (unii: 57gno57u7g) (finasteride - unii:57gno57u7g) - finasteride 1 mg - finasteride tablets are indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men only. efficacy in bitemporal recession has not been established. finasteride tablets are not indicated for use in women. finasteride tablets are contraindicated in the following: • pregnancy. finasteride use is contraindicated in women when they are or may potentially be pregnant. because of the ability of type ii 5α-reductase inhibitors to inhibit the conversion of testosterone to 5α-dihydrotestosterone (dht), finasteride may cause abnormalities of the external genitalia of a male fetus of a pregnant woman who receives finasteride. if this drug is used during pregnancy, or if pregnancy occurs while taking this drug, the pregnant woman should be apprised of the potential hazard to the male fetus. [see warnings and precautions (5.1), use in specific populations (8.1), how supplied/storage and handling (16) and patient counseling information (17.1).] in female rats, low doses of finasteride administered

Fintrid 5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

fintrid 5 mg film-coated tablets

aurobindo pharma (malta) limited - finasteride - film-coated tablet - 5 milligram(s) - testosterone-5-alpha reductase inhibitors; finasteride